HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Jan Marini Skin Research: San Jose, Calif. company launches Age Intervention Enlighten, "a remarkable new composition that brightens and encourages the uniform appearance of facial discoloration - even stubborn pigmentation," according to May 6 release. President and CEO Jan Marini states: "Women often associate fine lines and wrinkles with aging, but discoloration is an even more visual sign of the aging process." Product, available in 1-oz. pump, addresses facial discoloration due to melasma, cumulative sun exposure and ethnicity with two topical agents and anti-aging Retinol, awarding "more refined, rejuvenated and illuminated skin," according to company. In January, JMSR suspended sales of two Age Intervention eyelash products in the U.S. due to uncertain regulatory environment and pressure from pharma giant Allergan, which claimed its patent had been infringed. Marketed as a means of conditioning lashes and improving their volume, texture and density, the products had brought in roughly 30 percent of the company's domestic sales prior to suspension (1"The Rose Sheet" Jan. 14, 2008, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel